The role of biomarkers in the early detection of pancreatic cancer
Familial Cancer · 2024-08 · 23 (3) · 309-322
DOI: 10.1007/s10689-024-00381-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Familial Cancer, online erschienen am 25.04.2024. Verfasst von Michael Goggins. Beteiligte Einrichtung: Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, 1550 Orleans Street, Bal…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Early Detection of Cancer, Biomarkers, Tumor. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Stand Up To Cancer, National Cancer Institute.
Abstract (Originalsprache)
Pancreatic surveillance can detect early-stage pancreatic cancer and achieve long-term survival, but currently involves annual endoscopic ultrasound and MRI/MRCP, and is recommended only for individuals who meet familial/genetic risk criteria. To improve upon current approaches to pancreatic cancer early detection and to expand access, more accurate, inexpensive, and safe biomarkers are needed, but finding them has remained elusive. Newer approaches to early detection, such as using gene tests to personalize biomarker interpretation, and the increasing application of artificial intelligence approaches to integrate complex biomarker data, offer promise that clinically useful biomarkers for early pancreatic cancer detection are on the horizon.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, 1550 Orleans Street, Baltimore, MD, 21231, USA. mgoggins@jhmi.edu.
- Department of Medicine, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. mgoggins@jhmi.edu.
- Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. mgoggins@jhmi.edu.
Förderung
- NCI NIH HHS
- Stand Up To Cancer
- National Cancer Institute
Zitieren
APA
Goggins, M. (2024). The role of biomarkers in the early detection of pancreatic cancer. Familial Cancer, 23(3), 309-322. https://doi.org/10.1007/s10689-024-00381-4
Vancouver
Goggins M. The role of biomarkers in the early detection of pancreatic cancer. Familial Cancer. 2024;23(3):309-322. doi:10.1007/s10689-024-00381-4
BibTeX
@article{Goggins2024,
author = {Goggins, Michael},
title = {The role of biomarkers in the early detection of pancreatic cancer},
journal = {Familial Cancer},
year = {2024},
volume = {23},
number = {3},
pages = {309--322},
doi = {10.1007/s10689-024-00381-4}
}
EUVIMED